Molecular testing from stained slides Diagnostic challenges in lung - - PowerPoint PPT Presentation

molecular testing from stained slides
SMART_READER_LITE
LIVE PREVIEW

Molecular testing from stained slides Diagnostic challenges in lung - - PowerPoint PPT Presentation

Molecular testing from stained slides Diagnostic challenges in lung cancer cytology 17.6.18 Hanoch Goldshmidt. PhD, MBA TASMC WHAT IS ROSE? Rapid onsite evaluation, or ROSE, is a service that pathologists and cytotechnologists commonly


slide-1
SLIDE 1

Molecular testing from stained slides

Diagnostic challenges in lung cancer cytology 17.6.18

Hanoch Goldshmidt. PhD, MBA TASMC

slide-2
SLIDE 2

WHAT IS ROSE?

  • Rapid on‐site evaluation, or ROSE, is a service that

pathologists and cytotechnologists commonly perform to check the cellular content and adequacy of fine‐needle aspiration smears and biopsy touch imprints

  • What for?
  • inform the operator of the need to obtain additional samples and

avoid having to repeat the procedure

  • Preliminary diagnosis so that additional material can be requested
slide-3
SLIDE 3

EBUS ‐ endobronchial US

slide-4
SLIDE 4

CT‐guided

slide-5
SLIDE 5

Prepare the instruments TASMC ROSE PROCEDURE:

slide-6
SLIDE 6

Prepare the slides

slide-7
SLIDE 7

DRY and stain using Romanowsky Quik Diff protocol

slide-8
SLIDE 8

Diagnose and discuss with physician if another biopsy is needed. Save slides for further molecular tests

slide-9
SLIDE 9

ROSE during CT‐guided CNB / FNA

slide-10
SLIDE 10
  • “good purity of tumor DNA in cytology FNA samples when compared

with biopsy samples”

  • “DNA extracted from EBUS sourced cases (n =50) gave on average

twice the amount of DNA as that extracted from FFPE (n =325) (16 vs.8 ug total DNA, measured using Nanodrop)”

  • “DNA from FFPE required 1.6 amplicon repeats per patient to obtain

a result whereas DNA from EBUS cytofluid material required 0.46 amplicon repeats per patient”

Stevensont et al. Diagnostic Cytopathology. 2018;1–7

slide-11
SLIDE 11

Stevensont et al. Diagnostic Cytopathology. 2018;1–7

slide-12
SLIDE 12
  • “When paraffin‐embedded tissue is used for molecular testing of lung

cancer, CNB specimens are more likely than FNA specimens to provide adequate tissue for molecular testing.

  • Obtaining a sufficient FNA specimen depends on the tumor size and

the individual performing the biopsy”

slide-13
SLIDE 13

“During the study period, FNA samples were consistently more adequate for molecular testing than CT‐guided NCB samples, as seen in Tables 2 and 3, unlike the study by Schneider et al.” “Many variables are likely to play a role, including type of lesion;

  • perator experience and the material itself”

Arch Pathol Lab Med—Vol 141, March 2017

slide-14
SLIDE 14

Using cytology samples for molecular diagnosis TASMC

2018 ‐ Cases that we extracted cytology and FFPE DNA samples

2 4 6 8 10 12 14 RTPCR NGS

Sample types usage

CELL BLOCK CYTOLOGY FFPE

? ?

slide-15
SLIDE 15

DNA concentration and Quality

  • Data from cases with FFPE tissue + cytology

FFPE concentration(ng/ul) Cytology concentration (ng/ul) 35.5 7.5 median

extraction date sample nanodrop-ng/ul ng/ul-qubit dsDNA/total DNA rate 5.12.17 c17-03699 43 17.20 40% 25.3.18 c18-01233 2 0.08 4% 7.5.18 c18-09185 9 0.48 5% 12.3.18 18-02045-1 49 8.35 17% 20.3.18 18-06799 23.3 9.92 43% 26.2.18 18-00468 29 4.03 14%

Quality Quantity

slide-16
SLIDE 16

conclusion

  • Rapid onsite evaluation is a service that prevents repeating

procedures

  • Rapid onsite evaluation provides suitable material for molecular

testing including NGS and RT‐PCR.

  • When lung cancer material becomes so crucial for so many tests,

we should have good procedures to utilize all the available samples, including cytology smears

  • Factors to consider:
  • amount of material
  • Percentage of tumor cells
  • quality of DNA from these samples
slide-17
SLIDE 17

THANKS

  • Prof. Dov Hershkovitz
  • Dr. Irit Solar
  • Mrs. Lital Tayblum
  • Mr. Pavel Gurianov
  • Mrs.Ziva Ahron